December 5, 2024 10:51 AM EST

UK to limit access to Lilly’s Zepbound; VivaVision’s positive Phase 2

Plus, news about Atlas Venture:

NICE plans a limited rollout of Eli Lilly’s Zepbound: The UK’s drug price watchdog confirmed its

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

UK to lim­it ac­cess to Lil­ly’s Zep­bound; Vi­vaV­i­sion’s pos­i­tive Phase 2